Marie V. Daugan,Margot Revel,Romane Thouenon,Marie‐Agnès Dragon‐Durey,Tania Robe-Rybkine,Carine Torset,Nicolas S. Merle,Rémi Noé,Virginie Verkarre,Stéphane Oudard,Arnaud Méjean,Pierre Validire,Xavier Cathelineau,Rafael Sanchez‐Salas,Matthew C. Pickering,Isabelle Cremer,Audrey Mansuet‐Lupo,Marco Alifano,Catherine Sautès‐Fridman,Diane Damotte,Wolf H. Fridman,Lubka T. Roumenina
出处
期刊:Cancer immunology research [American Association for Cancer Research] 日期:2021-05-26卷期号:9 (8): 909-925被引量:56
The complement regulator factor H (FH) is shown to exert protumoral actions through an intracellular, noncanonical mechanism that alters proliferation, cell cycle, morphology, and migration in clear cell renal cell carcinoma and lung adenocarcinoma.